ISRCTN31894035已完成2 期
A phase II trial to investigate the safety of early high dose methylprednisolone in acute leprous neuritis and leprosy type 1 reactions with neuritis in Nepal
ondon School of Hygiene and Tropical Medicine (UK)0 个研究点目标入组 60 人开始时间: 2006年4月4日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Those with type 1 reaction with new nerve function impairment
- •2. Age 16-65 years
排除标准
- •1. Type 1 reaction without new nerve function impairment
- •2. Systemic corticosteroids in the preceding three months
- •3. Contraindications to steroids
- •4. Pregnancy
- •5. Severe active infection
- •6. Severe intercurrent illness
研究者
相似试验
进行中（未招募）
不适用
A phase II clinical trial to evaluate the safety and efficacy of interferon gamma in elevating frataxin levels in Friedreich ataxia patientsEUCTR2012-001881-14-ITAZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA
已完成
2 期
Phase IIb study of Pembrolizumab in combination with TS-1+Cisplatin or TS-1+Oxaliplatin in GCJPRN-jRCT2080223773Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.90
尚未招募
2 期
Phase II Study to evaluate efficacy and safety of Lenalidomide maintenance therapy for multiple myeloma patients under bortezomib treatmentmultiple myelomaJPRN-UMIN000013881ational Defense Medical College29
招募中
2 期
uPBSCT with PTCY for ATadult T-cell leukemia/lymphomaJPRN-jRCTs031200375Fukuda Takahiro24
招募中
不适用
Phase II study to evaluate efficacy and safety of retherapy with bendamustine and rituximab regimens in patients with relapsed/refractory indolent B-cell lymphomas and mantle cell lymphomasJPRN-UMIN000011152B-SRIM Study Group38